EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Ypsomed Holding AG's Enterprise Value is CHF4,973.0 Mil.
Ypsomed Holding AG's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was CHF-16.3 Mil. Therefore, Ypsomed Holding AG's EV-to-FCF for today is -304.27.
The historical rank and industry rank for Ypsomed Holding AG's EV-to-FCF or its related term are showing as below:
LTS:0QLQ'
s EV-to-FCF Range Over the Past 10 Years
Min: -313.94 Med: -48.45 Max: 75.62
Current: -303.79
During the past 13 years, the highest EV-to-FCF of Ypsomed Holding AG was 75.62. The lowest was -313.94. And the median was -48.45.
LTS:0QLQ's EV-to-FCF is ranked worse than 100% of 418
companies
in the Medical Devices & Instruments industry
Industry Median: 23.12
vs LTS:0QLQ: -303.79
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Ypsomed Holding AG (LTS:0QLQ) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Ypsomed Holding AG's PE Ratio (TTM) for today is calculated as:
Ypsomed Holding AG's share price for today is CHF359.40.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ypsomed Holding AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was CHF16.300.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Ypsomed Holding AG EV-to-FCF Related Terms
Ypsomed Holding AG EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Ypsomed Holding AG's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Ypsomed Holding AG's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ypsomed Holding AG EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ypsomed Holding AG's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Ypsomed Holding AG's EV-to-FCF falls into.
Ypsomed Holding AG's current Enterprise Value is CHF4,973.0 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ypsomed Holding AG's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was CHF-16.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ypsomed Holding AG (LTS:0QLQ) has a EV-to-FCF of -304.27 as of Jul. 03, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Ypsomed Holding AG and its competitors. According to the industry distribution chart, Ypsomed Holding AG ranks #999999 out of 418 companies in the Medical Devices & Instruments industry.
Is Ypsomed Holding AG's EV-to-FCF too high?
Ypsomed Holding AG's current EV-to-FCF is -304.27. Based on the distribution chart, Ypsomed Holding AG ranks #999999 out of 418 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Ypsomed Holding AG has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ypsomed Holding AG's EV-to-FCF compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Ypsomed Holding AG ranks #999999 out of 418 companies for EV-to-FCF. This places Ypsomed Holding AG in the lower half of its industry. The industry median EV-to-FCF is 23.12. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.12, based on 418 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Ypsomed Holding AG and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ypsomed Holding AG's current EV-to-FCF is -304.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ypsomed Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Ypsomed Holding AG (LTS:0QLQ) is currently considered Fairly Valued. The stock's GF Value™ is CHF397.17, compared to a current price of CHF359.40 — trading 9.5% below its estimated fair value. The current EV-to-FCF is -304.27. Ypsomed Holding AG's overall GF Score™ is 82/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Ypsomed Holding AG (LTS:0QLQ), the current EV-to-FCF is -304.27 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ypsomed Holding AG (LTS:0QLQ) Overvalued in 2026?
Based on GuruFocus' analysis, Ypsomed Holding AG stock appears to be undervalued.
The current stock price of CHF359.40 is trading 9.5% below its estimated GF Value™ of CHF397.17.
GuruFocus considers Ypsomed Holding AG to be Fairly Valued.
Key valuation signals for LTS:0QLQ:
EV-to-FCF: -304.27
GF Value™: CHF397.17 vs. price of CHF359.40 (9.5% below fair value)
No single metric tells the full story. See the LTS:0QLQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a click-on function. The company operates under two reportable segments: Ypsomed Delivery Systems and Ypsomed Diabetes Care.
82GF Score
Get the complete analysis for LTS:0QLQ
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0QLQ has been successfully added to your 
